Granzyme B: pro-apoptotic, antiviral and antitumor functions

被引:215
作者
Trapani, JA [1 ]
Sutton, VR [1 ]
机构
[1] Peter MacCallum Canc Ctr, Div Res, Canc Immunol Program, Melbourne, Vic 8006, Australia
基金
英国医学研究理事会;
关键词
D O I
10.1016/S0952-7915(03)00107-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Granzyme B is a caspase-like serine protease that is released by cytotoxic lymphocytes to kill virus-infected and tumor cells. Major recent advances in our understanding of granzyme B biochemistry, biology and function include an appreciation of its uptake into and trafficking within target cells, a thorough dissection of how cell death is triggered, and the identification of the serpin protease inhibitor PI-9, which regulates its function in lymphocytes and in other cells. The roles that granzyme B plays in human pathologies, such as transplant rejection, viral immunity and particularly tumor immune surveillance, remain a topic for vigorous debate and conjecture. The recent discovery of a triply mutated human granzyme B allele, whose product is predicted to possess a reduced capacity to induce cell death, opens the way for major progress in these areas in coming years.
引用
收藏
页码:533 / 543
页数:11
相关论文
共 92 条
[1]   Granzyme B induces BID-mediated cytochrome c release and mitochondrial permeability transition [J].
Alimonti, JB ;
Shi, LF ;
Baijal, PK ;
Greenberg, AH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (10) :6974-6982
[2]   Granzyme B directly and efficiently cleaves several downstream caspase substrates: Implications for CTL-induced apoptosis [J].
Andrade, F ;
Roy, S ;
Nicholson, D ;
Thornberry, N ;
Rosen, A ;
Casciola-Rosen, L .
IMMUNITY, 1998, 8 (04) :451-460
[3]   Adenovirus L4-100K assembly protein is a granzyme B substrate that potently inhibits granzyme B-mediated cell death [J].
Andrade, F ;
Bull, HG ;
Thornberry, NA ;
Ketner, GW ;
Casciola-Rosen, LA ;
Rosen, A .
IMMUNITY, 2001, 14 (06) :751-761
[4]   Concerted action of the FasL/Fas and perforin/granzyme A and B pathways is mandatory for the development of early viral hepatitis but not for recovery from viral infection [J].
Balkow, S ;
Kersten, A ;
Tran, TTT ;
Stehle, T ;
Grosse, P ;
Museteanu, C ;
Utermöhlen, O ;
Pircher, H ;
von Weizsäcker, F ;
Wallich, R ;
Müllbacher, A ;
Simon, MM .
JOURNAL OF VIROLOGY, 2001, 75 (18) :8781-8791
[5]   Granzyme B short-circuits the need for caspase 8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly cleaving bid [J].
Barry, M ;
Heibein, JA ;
Pinkoski, MJ ;
Lee, SF ;
Moyer, RW ;
Green, DR ;
Bleackley, RC .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (11) :3781-3794
[6]   Cytotoxic T lymphocytes: All roads lead to death [J].
Barry, M ;
Bleackley, RC .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (06) :401-409
[7]   Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway [J].
Bird, CH ;
Sutton, VR ;
Sun, JR ;
Hirst, CE ;
Novak, A ;
Kumar, S ;
Trapani, JA ;
Bird, PI .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (11) :6387-6398
[8]   Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system? [J].
Bladergroen, BA ;
Meijer, CJLM ;
ten Berge, RL ;
Hack, CE ;
Muris, JJF ;
Dukers, DF ;
Chott, A ;
Kazama, Y ;
Oudejans, JJ ;
van Berkum, O ;
Kummer, JA .
BLOOD, 2002, 99 (01) :232-237
[9]   The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites [J].
Bladergroen, BA ;
Strik, MCM ;
Bovenschen, N ;
van Berkum, O ;
Scheffer, GL ;
Meijer, CJLM ;
Hack, CE ;
Kummer, JA .
JOURNAL OF IMMUNOLOGY, 2001, 166 (05) :3218-3225
[10]   The mannose 6-phosphate/insulin-like growth factor II receptor is a nanomolar affinity receptor for glycosylated human leukemia inhibitory factor [J].
Blanchard, F ;
Raher, S ;
Duplomb, L ;
Vusio, P ;
Pitard, V ;
Taupin, JL ;
Moreau, JF ;
Hoflack, B ;
Minvielle, S ;
Jacques, Y ;
Godard, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (33) :20886-20893